| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8793980 | Ophthalmology | 2018 | 8 Pages |
Abstract
In this 3-year randomized trial of 40 eyes with DME, there was no evidence that combination therapy with ranibizumab and TRP improved visual outcomes or reduced treatment burden compared with ranibizumab alone.
Keywords
TrpDAVEGVFPDRBCVAETDRSPRNPrPCrtDMEpanretinal photocoagulationfluorescein angiographyDiabetic macular edemabest-corrected visual acuityspectral-domainearly treatment diabetic retinopathy studyProliferative diabetic retinopathypro re nataVascular Endothelial Growth Factor (VEGF)Vascular endothelial growth factor A
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
David M. MD, William C. BS, Tien P. MD, Rosa Y. MD, Daniel E. BA, Charles C. MD, PhD, DAVE Study Group DAVE Study Group,